# Clinical References

This document provides quick reference tables and scoring guides for the validated instruments included in the clinical toolkit.

**Last Updated:** 2026-02-01
**Status:** ðŸš§ To be populated during skill implementation

---

## Depression Screening

### PHQ-9 Scoring

| Score Range | Severity | Clinical Actions |
|-------------|----------|------------------|
| 0-4 | Minimal depression | *[To be added]* |
| 5-9 | Mild depression | *[To be added]* |
| 10-14 | Moderate depression | *[To be added]* |
| 15-19 | Moderately severe depression | *[To be added]* |
| 20-27 | Severe depression | *[To be added]* |

**Key Thresholds:**
- Score â‰¥10: Cutoff for major depression (88% sensitivity, 88% specificity)
- 5-point change: Indicates treatment response
- 10-point change: Clinically significant improvement

**Item 9 (Suicidal Ideation):** ANY score >0 requires immediate follow-up

### PHQ-2 Scoring

*[Scoring table and interpretation to be added]*

---

## Anxiety Screening

### GAD-7 Scoring

| Score Range | Severity | Clinical Actions |
|-------------|----------|------------------|
| 0-4 | Minimal anxiety | *[To be added]* |
| 5-9 | Mild anxiety | *[To be added]* |
| 10-14 | Moderate anxiety | *[To be added]* |
| 15-21 | Severe anxiety | *[To be added]* |

**Key Thresholds:**
- Score â‰¥8: High sensitivity (92%) and specificity (76%)
- Score â‰¥10: Commonly used cutoff for GAD
- 5-point change: Clinically significant improvement

### GAD-2 Scoring

*[Scoring table and interpretation to be added]*

---

## Ultra-Brief Screening

### PHQ-4 Scoring

**Total score (0-12):**
- 0-2: None
- 3-5: Mild
- 6-8: Moderate
- 9-12: Severe

**Subscales:**
- Anxiety (items 1-2): 0-6
- Depression (items 3-4): 0-6

**Triage guidance:** Total â‰¥6 or subscale â‰¥3 â†’ administer PHQ-9 and/or GAD-7.

---

## Distress Screening

### K6 / K10 Scoring (0-4 coding)

- K6 total range: 0-24
- K10 total range: 0-40
- Higher scores indicate greater distress.
- Use setting-specific cutoffs where available.

### Common Cutoffs (Verify Locally)

- **K6:** â‰¥13 is commonly used to indicate high likelihood of serious mental illness.
- **K10:** 10-19 likely well, 20-24 mild, 25-29 moderate, 30-50 severe.

---

## Trauma Screening

### PC-PTSD-5 Scoring

*[Scoring table and interpretation to be added]*

**Key Facts:**
- Yes/No format
- Score of 3-4 indicates positive screen
- Gender considerations: 4 for males, 3 for females may be optimal

### PCL-5 Scoring

| Score Range | Interpretation | Clinical Actions |
|-------------|----------------|------------------|
| 0-30 | Below PTSD threshold | *[To be added]* |
| 31-33 | Probable PTSD (provisional cutoff) | *[To be added]* |
| 34+ | Probable PTSD (higher confidence) | *[To be added]* |

**Key Thresholds:**
- 10-12 point change: Clinically significant improvement
- Score <28: May indicate return to healthy population range

**Subscale Structure:**
- Cluster B (Items 1-5): Re-experiencing
- Cluster C (Items 6-7): Avoidance
- Cluster D (Items 8-14): Negative cognitions/mood
- Cluster E (Items 15-20): Arousal/reactivity

---

## Substance Use Screening

### AUDIT-C Scoring

*[Scoring table and interpretation to be added]*

**Key Cutoffs:**
- Men: â‰¥4 indicates hazardous drinking
- Women: â‰¥3 indicates hazardous drinking

### DAST-10 Scoring

| Score Range | Severity | Clinical Actions |
|-------------|----------|------------------|
| 0 | No problems | *[To be added]* |
| 1-2 | Low level | *[To be added]* |
| 3-5 | Moderate level | *[To be added]* |
| 6-8 | Substantial level | *[To be added]* |
| 9-10 | Severe level | *[To be added]* |

---

## Suicide Risk Screening

### ASQ Interpretation

*[Scoring guide and response protocols to be added]*

**Key Principle:** ANY "yes" answer to questions 1-4 is a POSITIVE SCREEN requiring immediate evaluation

### C-SSRS Interpretation

*[Detailed scoring and risk stratification to be added]*

**Risk Levels:**
- Low: Passive ideation, no intent, no plan, no behavior
- Moderate: Active ideation without specific plan
- High: Active ideation with plan and/or intent
- Imminent: Plan + intent + means, or recent attempt

---

## Measurement-Based Care

### Reliable Change Index (RCI)

*[Tables for calculating reliable change for each instrument to be added]*

### Clinically Significant Change

*[Guidelines for determining clinically meaningful improvement to be added]*

### Outcome Tracking Template

Template: [docs/templates/outcome-tracking.md](templates/outcome-tracking.md)

---

## Sleep Tracking

### Consensus Sleep Diary (CSD)

- Use the official unaltered diary form for 1-2 weeks.
- Summarize trends in sleep onset latency, awakenings, and total sleep time.
- See the CSD project site for the official form and citation requirements.

---

## Motivation Assessment

### Readiness Ruler (Brief)

- 0-3: Precontemplation
- 4-6: Contemplation
- 7-8: Preparation
- 9-10: Action/Maintenance

### URICA (Stage Profile)

- Calculate stage subscales and identify dominant stage.
- Use stage-matched interventions to guide approach.
- UMBC HABITS Lab lists TTM measures (including URICA) as public domain.

---

## Original Nonâ€‘Validated Tools

These tools are original checklists and interview guides. They are **not validated instruments** and are **not diagnostic**.

- Bipolar Risk Interview Guide
- Functional Impairment Interview
- Eating Risk Checklist
- Cognitive Concerns Intake

---

## Medication Safety

### Opioid MME

- Use CDC conversion factors for MME calculations.
- Do not use MME for equianalgesic conversion when switching opioids.
- Use extra caution with methadone and fentanyl.

---

## Cross-Tool Workflow Chaining

### Depression Pathway

**Use when:** universal screening, depression complaints, or positive PHQ-2.

1. PHQ-4 (if available) for ultra-brief screen
2. PHQ-9 for severity and treatment monitoring

### Distress Pathway

**Use when:** nonspecific distress or high K6/K10 scores.

1. K6 or K10 for distress screening
2. PHQ-9 and GAD-7 for symptom specificity
3. Suicide risk assessment if distress is severe or safety concerns emerge

### Sleep Pathway

**Use when:** sleep complaints or early treatment response tracking.

1. Consensus Sleep Diary (CSD) for 1-2 weeks
2. PHQ-9 to evaluate depressive symptoms
3. GAD-7 to evaluate anxiety symptoms
4. Substance use screen if indicated (AUDIT-C/DAST-10)

### Adolescent Pathway

**Use when:** adolescent intakes or general mental health screening.

1. PHQ-4 (or PHQ-2/GAD-2 if PHQ-4 not available)
2. HEADSS for structured adolescent intake

---

## Crisis Resources

**National Resources:**
- 988 Suicide & Crisis Lifeline: Call or text 988
- Crisis Text Line: Text HOME to 741741
- Veterans Crisis Line: 988 then Press 1
- SAMHSA National Helpline: 1-800-662-4357
- Emergency Services: 911

---

## Instrument Sources & Attribution

**PHQ-9 & PHQ-2:**
- Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke
- Public domain, no copyright restrictions
- Source: https://www.phqscreeners.com

**GAD-7 & GAD-2:**
- Developed by Drs. Robert L. Spitzer, Kurt Kroenke, Janet B.W. Williams, Bernd LÃ¶we
- Public domain, no copyright restrictions
- Source: https://www.phqscreeners.com

**PC-PTSD-5 & PCL-5:**
- VA National Center for PTSD
- Public domain
- Source: https://www.ptsd.va.gov

**C-SSRS:**
- Columbia Lighthouse Project
- Free with attribution
- Source: https://cssrs.columbia.edu

**ASQ:**
- National Institute of Mental Health (NIMH)
- Public domain
- Source: https://www.nimh.nih.gov/asq

**AUDIT-C:**
- World Health Organization adaptation
- Freely available
- Source: Various public health sources

**DAST-10:**
- Harvey A. Skinner
- Freely available for clinical use
- Source: Various public health sources

**PHQ-4:**
- Part of the PHQ family; permitted for reproduction and use without permission
- Source: https://www.phqscreeners.com

**Consensus Sleep Diary (CSD):**
- Free for notâ€‘forâ€‘profit use with citation; use unaltered official form
- Source: https://consensussleepdiary.com

**URICA / TTM Measures:**
- UMBC HABITS Lab indicates most TTM measures (including URICA) are public domain
- Source: https://habitslab.umbc.edu/ttm-measures/

**Opioid MME Conversion Factors:**
- CDC conversion factor table (MME) and cautions
- Source: https://www.cdc.gov/opioids/providers/prescribing/guideline.html

**K6 / K10:**
- Kessler Psychological Distress Scales; free to use with citation
- Source: https://www.hcp.med.harvard.edu/ncs/k6_scales.php

**WHO-5:**
- WHO-5 Well-Being Index; free of charge and no permission required
- Source: https://www.psykiatri-regionh.dk/who-5/who-5-questionnaires/Pages/default.aspx

---

**Note:** This reference document will be expanded with detailed scoring tables, interpretation guidelines, and clinical action recommendations during the implementation phase of each skill.
